BREAKTHROUGH COVID-19

BREAKTHROUGH COVID-19 was reported 230 times

BREAKTHROUGH COVID-19 is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Endoglycosidase [EPC] 1 0.0005
2 CD38-directed Cytolytic Antibody [EPC] 2 0.0003
3 Human Immunoglobulin G [EPC] 7 0.0003
4 Antimetabolite Immunosuppressant [EPC] 7 0.0003
5 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 1 0.0003
6 CD20-directed Cytolytic Antibody [EPC] 93 0.0003
7 Provitamin D2 Compound [EPC] 7 0.0002
8 RNA Synthetase Inhibitor Antibacterial [EPC] 3 0.0002
9 B Lymphocyte Stimulator-specific Inhibitor [EPC] 6 0.0002
10 Alkylating Drug [EPC] 32 0.0001
11 Vitamin K [EPC] 1 0.0001
12 Purine Antimetabolite [EPC] 9 0.0001
13 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
14 Aminosalicylate [EPC] 7 0.0001
15 Folate Analog Metabolic Inhibitor [EPC] 30 0.0001
16 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
17 Corticosteroid [EPC] 72 0.0001
18 Complement Inhibitor [EPC] 3 0.0001
19 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
20 Interleukin-6 Receptor Antagonist [EPC] 7 0.0001
21 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
22 Antirheumatic Agent [EPC] 5 0.0000
23 PCSK9 Inhibitor [EPC] 1 0.0000
24 Alkaloid [EPC] 1 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
26 Integrin Receptor Antagonist [EPC] 3 0.0000
27 Leukotriene Receptor Antagonist [EPC] 1 0.0000
28 Interleukin-12 Antagonist [EPC] 3 0.0000
29 Interleukin-23 Antagonist [EPC] 3 0.0000
30 Interleukin-17A Antagonist [EPC] 1 0.0000
31 Proteasome Inhibitor [EPC] 3 0.0000
32 Thiazide-like Diuretic [EPC] 1 0.0000
33 Amide Local Anesthetic [EPC] 2 0.0000
34 Opioid Agonist [EPC] 6 0.0000
35 Selective T Cell Costimulation Modulator [EPC] 3 0.0000
36 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
37 Antiarrhythmic [EPC] 2 0.0000
38 Ester Local Anesthetic [EPC] 1 0.0000
39 Janus Kinase Inhibitor [EPC] 3 0.0000
40 Phosphodiesterase 4 Inhibitor [EPC] 3 0.0000
41 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
42 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
43 Thalidomide Analog [EPC] 8 0.0000
44 Tetracycline-class Drug [EPC] 1 0.0000
45 HER2/neu Receptor Antagonist [EPC] 1 0.0000
46 Tumor Necrosis Factor Blocker [EPC] 13 0.0000
47 Non-Standardized Chemical Allergen [EPC] 1 0.0000
48 Aldosterone Antagonist [EPC] 2 0.0000
49 Catecholamine [EPC] 1 0.0000
50 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
51 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
52 Platinum-based Drug [EPC] 3 0.0000
53 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
54 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
55 Acetylcholine Release Inhibitor [EPC] 1 0.0000
56 Expectorant [EPC] 2 0.0000
57 Anti-epileptic Agent [EPC] 2 0.0000
58 Atypical Antipsychotic [EPC] 4 0.0000
59 Aromatase Inhibitor [EPC] 1 0.0000
60 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
61 Nonsteroidal Anti-inflammatory Drug [EPC] 10 0.0000
62 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
63 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
64 alpha-Adrenergic Blocker [EPC] 1 0.0000
65 Proton Pump Inhibitor [EPC] 4 0.0000
66 Calcium [EPC] 1 0.0000
67 beta-Adrenergic Blocker [EPC] 2 0.0000
68 Kinase Inhibitor [EPC] 3 0.0000
69 Estrogen [EPC] 1 0.0000
70 Platelet Aggregation Inhibitor [EPC] 3 0.0000
71 RANK Ligand Inhibitor [EPC] 1 0.0000
72 Thiazide Diuretic [EPC] 1 0.0000
73 Loop Diuretic [EPC] 2 0.0000
74 Factor Xa Inhibitor [EPC] 1 0.0000
75 Progestin [EPC] 1 0.0000
76 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
77 Vitamin C [EPC] 1 0.0000
78 GLP-1 Receptor Agonist [EPC] 1 0.0000
79 Insulin Analog [EPC] 1 0.0000
80 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
81 Benzodiazepine [EPC] 1 0.0000